Heron Therapeutics Inc
Research Heron Therapeutics Inc (HRTX) on Bullrun: market cap USD 60.63M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHRTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 60.63M
- Financial periodQ1 2026
- RevenueUSD 34.71M
- Net income-USD 8.11M
- Free cash flow-USD 20.86M
- Gross margin308.8%
Valuation Snapshot
latest market cap is USD 60.63M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 154.90M | -USD 20.00M | -USD 27.91M | 73.3% | -0.12 | USD 28.65M | USD 140.64M | USD 14.33M |
| FY2024 | USD 144.29M | -USD 14.00M | -USD 24.24M | 73.2% | -0.09 | USD 25.80M | USD 177.76M | -USD 33.65M |
| FY2023 | USD 127.04M | -USD 111.00M | -USD 60.33M | 48.8% | -0.8 | USD 28.68M | USD 179.63M | -USD 33.97M |
| FY2022 | USD 107.67M | -USD 182.00M | -USD 148.74M | 49.0% | -1.67 | USD 15.36M | USD 158.51M | USD 13.57M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 60.63M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 244.81M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 232.76M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 255.12M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 297.22M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 931.31M | n/a | n/a | n/a |
About Heron Therapeutics Inc
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Heron Therapeutics Inc's market cap?
Heron Therapeutics Inc's market capitalization is USD 60.63M.
What does Heron Therapeutics Inc do?
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.